520 related articles for article (PubMed ID: 18097037)
1. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
[TBL] [Abstract][Full Text] [Related]
2. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of the plasma cell pool is independent of memory B cells.
Ahuja A; Anderson SM; Khalil A; Shlomchik MJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4802-7. PubMed ID: 18339801
[TBL] [Abstract][Full Text] [Related]
4. An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
Gollackner B; Ryan D; Knosalla C; Basker M; Alwayn IP; Harper D; Salomon G; Mauiyyedi S; Correa L; Thall A; Cooper DK
Xenotransplantation; 2003 Jan; 10(1):80-7. PubMed ID: 12535229
[TBL] [Abstract][Full Text] [Related]
5. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
Hamaguchi Y; Uchida J; Cain DW; Venturi GM; Poe JC; Haas KM; Tedder TF
J Immunol; 2005 Apr; 174(7):4389-99. PubMed ID: 15778404
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A
PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021
[TBL] [Abstract][Full Text] [Related]
7. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
8. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
9. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
Bhoj VG; Arhontoulis D; Wertheim G; Capobianchi J; Callahan CA; Ellebrecht CT; Obstfeld AE; Lacey SF; Melenhorst JJ; Nazimuddin F; Hwang WT; Maude SL; Wasik MA; Bagg A; Schuster S; Feldman MD; Porter DL; Grupp SA; June CH; Milone MC
Blood; 2016 Jul; 128(3):360-70. PubMed ID: 27166358
[TBL] [Abstract][Full Text] [Related]
10. B lymphocytes differentially influence acute and chronic allograft rejection in mice.
DiLillo DJ; Griffiths R; Seshan SV; Magro CM; Ruiz P; Coffman TM; Tedder TF
J Immunol; 2011 Feb; 186(4):2643-54. PubMed ID: 21248259
[TBL] [Abstract][Full Text] [Related]
11. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
[TBL] [Abstract][Full Text] [Related]
12. Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab).
Gonzalez-Stawinski GV; Yu PB; Love SD; Parker W; Davis RD
Clin Immunol; 2001 Feb; 98(2):175-9. PubMed ID: 11161973
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
Minard-Colin V; Xiu Y; Poe JC; Horikawa M; Magro CM; Hamaguchi Y; Haas KM; Tedder TF
Blood; 2008 Aug; 112(4):1205-13. PubMed ID: 18495955
[TBL] [Abstract][Full Text] [Related]
15. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
[TBL] [Abstract][Full Text] [Related]
16. Allergy for a lifetime?
Luger EO; Wegmann M; Achatz G; Worm M; Renz H; Radbruch A
Allergol Int; 2010 Mar; 59(1):1-8. PubMed ID: 20186004
[TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells.
Foote JB; Mahmoud TI; Vale AM; Kearney JF
J Immunol; 2012 Jan; 188(1):57-67. PubMed ID: 22116821
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
Langley WA; Wieland A; Ahmed H; Rasheed MAU; Davis CW; Sewatanon J; Mueller SN; Shlomchik MJ; Zarnitsyna VI; Antia R; Ahmed R
J Virol; 2022 May; 96(9):e0002622. PubMed ID: 35404084
[TBL] [Abstract][Full Text] [Related]
19. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.
Lin WY; Gong Q; Seshasayee D; Lin Z; Ou Q; Ye S; Suto E; Shu J; Lee WP; Lee CW; Fuh G; Leabman M; Iyer S; Howell K; Gelzleichter T; Beyer J; Danilenko D; Yeh S; DeForge LE; Ebens A; Thompson JS; Ambrose C; Balazs M; Starovasnik MA; Martin F
Blood; 2007 Dec; 110(12):3959-67. PubMed ID: 17687108
[TBL] [Abstract][Full Text] [Related]
20. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
Baert L; Manfroi B; Casez O; Sturm N; Huard B
J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
